Dentsply Sirona (XRAY) Tops Q2 EPS by 2c, provides guidance

Dentsply Sirona (NASDAQ: XRAY) reported Q2 EPS of $0.52, $0.02 better than the analyst estimate of $0.50. Revenue for the quarter came in at $936 million versus the consensus estimate of $933.63 million.

GUIDANCE:

Dentsply Sirona sees FY2025 EPS of $1.80-$2.00, versus the consensus of $1.88. Dentsply Sirona sees FY2025 revenue of $3.6-3.7 billion, versus the consensus of $3.65 billion.

For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Jefferies cuts China online beauty outlook after July slowdown
• The OLB Group Reports Second Quarter 2026 Results and Completes Company-Wide Transition to AI-Assisted Software Development